journal article·2025-08Open access

3D printing of biodegradable polymer vascular stents to treat cardiovascular diseases: A review

Yi Huang, Yan Xu, Xiaolong Chen, James P.K. Armstrong, Massimo Caputo, Qunfen Qi, Ben Hicks, Cian Vyas, Paulo Bartolo, Giovanni Biglino, Fengyuan Liu

Abstract

Cardiovascular diseases (CVDs), the leading cause of mortality worldwide, stem from structural and functional abnormalities in the heart and blood vessels. Although advancements in treatments such as percutaneous coronary intervention and vascular stent implantation have reduced complications, challenges such as restenosis, late thrombosis, and limited customisation remain. Biodegradable polymer vascular stents (BPVSs) have emerged as promising alternatives to traditional metallic stents, offering advantages such as controlled degradation, improved biocompatibility, and reduced late-stage complications. This review examines the integration of 3D printing (3DP) techniques, including material extrusion, vat photopolymerisation, powder bed fusion, material jetting, and binder jetting into BPVS fabrication, highlighting their potential to enhance material properties, manufacturing processes, and clinical applicability. Key topics include material selection, structural design optimisation, and mechanical characterisation of 3DP BPVSs. The review also discusses preclinical evaluations and updated clinical insights, concluding with future research directions, including advanced materials development, innovative structural designs, breakthroughs in high-resolution 3DP techniques, and challenges in regulatory approval and clinical translation. These advancements underscore the potential of 3DP BPVSs to revolutionize personalised CVD treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Additive Manufacturing and 3D Printing Technologies · Electrospun Nanofibers in Biomedical Applications · Anatomy and Medical Technology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease10.3390/ijms25021082 ↗
2. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study10.1016/j.jacc.2020.11.010 ↗
3. Coronary artery disease in patients≥ 80 years of age10.1016/j.jacc.2017.12.068 ↗
4. The comparison between management versus percutaneous coronary intervention (PCI) patients with coronary artery disease (CAD)
5. The role of metabolic disorders in the development of atherosclerosis10.14715/cmb/2024.70.9.21 ↗
6. A review on coronary artery disease
7. Coronary artery disease: from mechanism to clinical practice
8. Updates emergency ischemic chest pain
9. Percutaneous treatment of adult isthmic aortic coarctation: acute and long-term clinical and imaging outcome with a self-expandable uncovered nitinol stent
10. Diagnostic approach in fetal coarctation of the aorta: a cost-utility analysis10.1016/j.echo.2017.01.019 ↗
11. Balloon dilatation and stenting for aortic coarctation: a systematic review and meta-analysis
12. Left ventricular response to pressure afterload in children: aortic stenosis and coarctation: a systematic review of the current evidence10.1016/j.ijcard.2014.10.089 ↗
13. The importance of the early diagnosis of aorta coarctation10.1590/1806-9282.65.2.240 ↗
14. Coarctation of the aorta: management from infancy to adulthood10.4330/wjc.v7.i11.765 ↗
15. Challenges and advances in interventional cardiology for coronary artery disease management10.3390/medicina60081323 ↗
16. Percutaneous coronary intervention with drug-eluting stents versus coronary bypass surgery for coronary artery disease: a Bayesian perspective
17. 3D printing advances in the development of stents10.1016/j.ijpharm.2021.121153 ↗
18. Absorbable stent: focus on clinical applications and benefits10.2147/VHRM.S22551 ↗
19. Bioresorbable scaffolds: rationale, current status, challenges, and future10.1093/eurheartj/eht542 ↗
20. Bioresorbable scaffolds for percutaneous coronary interventions
21. Advances in the development of biodegradable coronary stents: a translational perspective
22. Coronary stents: historical development, current status and future directions10.1093/bmb/ldt009 ↗
23. Advances in fabrication technologies for the development of next-generation cardiovascular stents10.3390/jfb14110544 ↗
24. Bioresorbable scaffold technologies10.1253/circj.CJ-10-1135 ↗
25. In-stent restenosis and a drug-coated balloon: insights from a clinical therapeutic strategy on coronary artery diseases
26. Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents10.4244/JV4I4A82 ↗
27. Radial compressive property and the proof-of-concept study for realizing self-expansion of 3D printing polylactic acid vascular stents with negative Poisson’s ratio structure10.3390/ma11081357 ↗
28. Heparin coating on 3D printed poly (l-lactic acid) biodegradable cardiovascular stent via mild surface modification approach for coronary artery implantation10.1016/j.cej.2019.122116 ↗
29. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial10.1016/S0140-6736(08)60415-8 ↗
30. Computational and experimental investigation into mechanical performances of Poly-L-Lactide acid (PLLA) coronary stents10.1016/j.jmbbm.2016.08.033 ↗
31. Biodegradable polymer material based smart stent: wireless pressure sensor and 3D printed stent10.1016/j.mee.2018.12.007 ↗
32. Design, characterization, and 3D printing of cardiovascular stents with zero Poisson’s ratio in longitudinal deformation10.1016/j.eng.2020.02.013 ↗
33. A promising biodegradable magnesium alloy suitable for clinical vascular stent application10.1038/srep46343 ↗
34. Zinc-based alloys for degradable vascular stent applications10.1016/j.actbio.2018.03.005 ↗
35. Diagnosis, imaging and clinical management of aortic coarctation10.1136/heartjnl-2017-311173 ↗
36. Coarctation of the aorta in adolescents and adults: a review of clinical features and CT imaging10.1016/j.jcct.2015.11.002 ↗
37. Coarctation: a review10.15420/usc.2019.15.2 ↗
38. Implantation and intermediate-term follow-up of stents in congenital heart disease10.1161/01.CIR.88.2.605 ↗
39. Coarctation of aorta in children10.7759/cureus.3690 ↗
40. 3D-printed multidrug-eluting stent from graphene-nanoplatelet-doped biodegradable polymer composite10.1002/adhm.201700008 ↗
41. Improved stents for pediatric applications10.1016/S1058-9813(01)00125-4 ↗
42. A resorbable bicomponent braided ureteral stent with improved mechanical performance10.1016/j.jmbbm.2014.06.004 ↗
43. Fibre laser cutting and chemical etching of AZ31 for manufacturing biodegradable stents10.1155/2013/692635 ↗
44. Advancements in 3D printing techniques for biomedical applications: a comprehensive review of materials consideration, post processing, applications, and challenges10.1007/s43939-024-00115-4 ↗
45. 3D printed personalized, heparinized and biodegradable coronary artery stents for rabbit abdominal aorta implantation10.1016/j.cej.2022.138202 ↗
46. 3D-printed bioabsordable polycaprolactone stent: the effect of process parameters on its physical features10.1016/j.matdes.2017.10.045 ↗
47. Biomechanical challenges to polymeric biodegradable stents10.1007/s10439-015-1477-2 ↗
48. 3D printing of biodegradable polymer vascular stents: a review
49. Current status and future direction of biodegradable metallic and polymeric vascular scaffolds for next-generation stents10.1016/j.actbio.2017.07.019 ↗
50. 3D-printed bioresorbable vascular stents: emerging frontiers in personalized cardiac care10.1007/s00289-024-05237-6 ↗
51. Bio-resorbable polymer stents: a review of material progress and prospects10.1016/j.progpolymsci.2018.05.002 ↗
52. Structural design of vascular stents: a review10.3390/mi12070770 ↗
53. A biodegradable poly-l-lactic acid coronary stent in the porcine coronary artery10.1111/j.1540-8183.1999.tb00673.x ↗
54. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans10.1161/01.CIR.102.4.399 ↗
55. Promise and challenges of bioabsorbable stents
56. Long-term (> 10 years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents10.1161/CIRCULATIONAHA.110.000901 ↗
57. Bioresorbable scaffolds: current evidence and ongoing clinical trials10.1007/s11886-012-0295-5 ↗
58. First-in-human implantation of a fully bioabsorbable drug-eluting stent: the BVS poly-L-lactic acid everolimus-eluting coronary stent
59. The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology
60. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease
61. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials
62. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study10.1161/CIRCINTERVENTIONS.112.971549 ↗
63. OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold10.1016/j.jacc.2014.09.029 ↗
64. The current literature on bioabsorbable stents: a review10.1007/s11883-019-0816-4 ↗
65. Fully biodegradable coronary stents: progress to date10.2165/00129784-200808050-00003 ↗
66. The development of design and manufacture techniques for bioresorbable coronary artery stents10.3390/mi12080990 ↗
67. Progress in treatment by percutaneous coronary intervention: the stent of the future10.1016/j.recesp.2012.12.009 ↗
68. Bioresorbable scaffolds in coronary intervention: unmet needs and evolution10.4070/kcj.2017.0194 ↗
69. Bioabsorbable coronary stents10.1161/CIRCINTERVENTIONS.109.859173 ↗
70. Coronary stents: novel developments10.1136/heartjnl-2012-303522 ↗
71. Novel fully bioabsorbable salicylate-based sirolimus-eluting stent10.4244/EIJV5IFA10 ↗
72. Bioresorbable scaffolds: current knowledge, potentialities and limitations experienced during their first clinical applications10.1016/j.ijcard.2012.05.093 ↗
73. The DESolve® novolimus bioresorbable scaffold10.2217/fca-2020-0042 ↗
74. The DESolve novolimus bioresorbable scaffold: from bench to bedside10.21037/jtd.2017.07.25 ↗
75. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6-and 12-month clinical and multimodality imaging results, JACC cardiovasc. Interv
76. TCT-32 prospective, multi-center evaluation of the DESolve novolimus-eluting bioresorbable coronary scaffold: imaging outcomes and 4-year clinical and imaging results10.1016/j.jacc.2016.09.053 ↗
77. TCT-330 multi-center evaluation of a novel 120 μm novolimus-eluting, fully bioresorbable coronary scaffold: first report of 6-month imaging and 12-month clinical results10.1016/j.jacc.2017.09.418 ↗
78. Long-term outcomes following bioresorbable vascular scaffolds10.1080/14779072.2024.2375340 ↗
79. ART: concept of a bioresorbable stent without drug elution10.4244/EIJV5IFA14 ↗
80. OrbusNeich fully absorbable coronary stent platform incorporating dual partitioned coatings10.4244/EIJV5IFA11 ↗
81. Additive manufacturing of vascular stents10.1016/j.actbio.2023.06.014 ↗
82. P&S Market Research, 3D Printing Market: Global Industry Analysis and Forecast (2024–2030). 〈https://www.psmarketresearch.com/market-analysis/3d-printing-market〉, 2024 (accessed 20 July 2025).
83. Experimental study of polymeric stent fabrication using homemade 3D printing system10.1002/pen.25091 ↗
84. A novel 3D additive manufacturing machine to biodegradable stents10.1016/j.promfg.2017.09.118 ↗
85. Development of 3D printable bioresorbable drug eluting coronary stents: an experimental and computational investigation
86. Multi-objective optimization of solvent cast 3D printing process parameters for fabrication of biodegradable composite stents10.1007/s00170-021-07423-6 ↗
87. A comparative analysis of solvent cast 3D printed carbonyl iron powder reinforced polycaprolactone polymeric stents for intravascular applications10.1002/jbm.b.34795 ↗
88. Personalized, mechanically strong, and biodegradable coronary artery stents via melt electrowriting10.1021/acsmacrolett.0c00644 ↗
89. Heterotypic scaffold design orchestrates primary cell organization and phenotypes in cocultured small diameter vascular grafts10.1002/adfm.201905987 ↗
90. 3D-printed PCL/PLA composite stents: towards a new solution to cardiovascular problems10.3390/ma11091679 ↗
91. in vivo evaluation and characterization of a bio-absorbable drug-coated stent fabricated using a 3D-printing system10.1016/j.matlet.2014.11.119 ↗
92. Bioresorbable PPDO sliding-lock stents with optimized FDM parameters for congenital heart disease treatment10.1016/j.jmbbm.2022.105609 ↗
93. FDM process parameters influence over the mechanical properties of polymer specimens: a review10.1016/j.polymertesting.2018.05.020 ↗
94. Additive manufacturing solidification methodologies for ink formulation
95. Chemical vs thermal accelerated hydrolytic degradation of 3D-printed PLLA/PLCL bioresorbable stents: characterization and influence of sterilization10.1016/j.polymertesting.2022.107817 ↗
96. Solvent-cast direct-writing as a fabrication strategy for radiopaque stents
97. Advances in melt electrowriting for cardiovascular applications10.3389/fbioe.2024.1425073 ↗
98. Direct 3D printing of thin-walled cardiovascular stents with negative Poisson’s ratio (NPR) structure and functional metallic coating10.1016/j.compstruct.2022.116572 ↗
99. An innovative stereolithography 3D tubular method for ultrathin polymeric stent manufacture: the effect of process parameters10.3390/polym15214298 ↗
100. 3D printed bioresorbable nitric oxide-releasing vascular stents10.1016/j.bprint.2021.e00137 ↗